Trial Profile
Use of Selincro and Impact on Usual Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 May 2018
Price :
$35
*
At a glance
- Drugs Nalmefene (Primary)
- Indications Alcoholism
- Focus Therapeutic Use
- Acronyms USE-PACT
- 03 May 2018 Status changed from active, no longer recruiting to completed.
- 26 Apr 2017 Planned End Date changed from 1 Nov 2017 to 1 Feb 2018.
- 26 Apr 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Feb 2018.